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Molecular Biology, and Biophysics, University of Minnesota, Minneapolis, MinnesotaABSTRACT The sarcoendoplasmic reticulum calcium ATPase (SERCA) plays a key role in cardiac calcium handling and is
considered a high-value target for the treatment of heart failure. SERCA undergoes conformational changes as it harnesses
the chemical energy of ATP for active transport. X-ray crystallography has provided insight into SERCA structural substates,
but it is not known how well these static snapshots describe in vivo conformational dynamics. The goals of this work were to
quantify the direction and magnitude of SERCA motions as the pump performs work in live cardiac myocytes, and to identify
structural determinants of SERCA regulation by phospholamban. We measured intramolecular fluorescence resonance energy
transfer (FRET) between fluorescent proteins fused to SERCA cytoplasmic domains. We detected four discrete structural sub-
states for SERCA expressed in cardiac muscle cells. The relative populations of these discrete states oscillated with electrical
pacing. Low FRET states were most populated in low Ca (diastole), and were indicative of an open, disordered structure for
SERCA in the E2 (Ca-free) enzymatic substate. High FRET states increased with Ca (systole), suggesting rigidly closed con-
formations for the E1 (Ca-bound) enzymatic substates. Notably, a special compact E1 state was observed after treatment with
b-adrenergic agonist or with coexpression of phosphomimetic mutants of phospholamban. The data suggest that SERCA
calcium binding induces the pump to undergo a transition from an open, dynamic conformation to a closed, ordered structure.
Phosphorylated phospholamban stabilizes a unique conformation of SERCA that is characterized by a compact architecture.INTRODUCTIONThe sarco(endo)plasmic reticulum Ca-ATPase (SERCA) is
a P-type ion pump responsible for transporting Ca ions
from the cytoplasm to sarcoendoplasmic reticulum (SR) in
muscle cells. This process is critical during cardiac diastole
(relaxation), because the muscle must relax to allow for
adequate filling of the ventricles with blood. SERCA func-
tion is also important for systole (cardiac contraction),
because it is solely responsible for creating the large store
of SR Ca that is released to initiate activation of the muscle.
Disordered SERCA expression (1), function (2), or regula-
tion (3–5) are associated with heart disease, underscoring
the central role of SERCA in cardiac physiology.
Biochemical and biophysical studies employing a vari-
ety of methods have provided insight into SERCA struc-
ture/function relationships. As examples, conformational
changes of SERCA have been studied by quantification of
spectroscopic changes (6) fluorescence anisotropy decay
of an N-domain or P-domain-targeted probe (7), partial pro-
teolysis (7,8), transient phosphorescence anisotropy (9),
molecular dynamics simulations (10,11), or by quantifying
the altered crosslinking of phospholamban (PLB) (or other
regulators) with the pump (12–14). We and others have
also quantified pump dynamics with intramolecular FRET
between fluorescent labels attached to SERCA cytoplasmic
domains (15–18). Collectively, these biochemical studiesSubmitted April 5, 2013, and accepted for publication August 26, 2013.
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cycle are accompanied by conformational changes between
two broad classes of structures. These are the E1 (Ca-bound)
and E2 (Ca-free) conformations, characterized by different
relative positions of three cytoplasmic domains (N, A,
and P), collectively known as the ‘‘cytoplasmic headpiece’’.
Moreover, a series of high-resolution structure solutions
have elucidated SERCA enzymatic substates in atomic
detail (reviewed in Moller et al. (19)), revealing how confor-
mational changes in the headpiece are transmitted to the
trans-membrane domain to alter the occlusion and affinity
of the Ca binding sites. The first x-ray crystal structures of
SERCA suggested that Ca induces a large increase in the
separation of the N and A domains (20,21), but recent crys-
tallography (22–24) and in vitro fluorescence resonance
energy transfer (FRET) experiments (18) depict a closed
cytoplasmic headpiece for Ca-bound SERCA, and suggest
that the conformational change may be smaller than previ-
ously thought.
To investigate SERCA conformational changes in live
cells, we previously utilized a two-color SERCA construct
composed of SERCA2a fused to a Cerulean (Cer) FRET
donor and a yellow fluorescent protein (YFP) FRET
acceptor ((16) and S. J. Gruber, R. L. Cornea, J. Li, K. C.
Peterson, T. M. Schaaf, G. D. Gillispie, R. Dahl, K. M.
Zsebo, S. L. Robia, and D. D. Thomas, unpublished) (CY-
SERCA, Fig. 1 A). Several variants of this intramolecular
FRET sensor were characterized and shown to be functional
with respect to subcellular localization, ATPase activity,http://dx.doi.org/10.1016/j.bpj.2013.08.045
FIGURE 1 Single molecule fluorescence spectroscopy of two-color
SERCA. (A) CY-SERCA comprises a Cerulean FRET donor fused to the
N-terminus of SERCA (gray) in the actuator, or A-domain, and an intrase-
quence YFP inserted in the nucleotide-binding, or N-domain (16). (B) RG-
SERCA is an analogous construct composed of a TagRFP acceptor fused to
the N-terminus in the A-domain and GFP (green) donor inserted in the
N-domain. Changes in SERCA conformation alter the distance between the
N- and A-domains, changing intramolecular FRET efficiency. (C) Fluores-
cence bursts from single molecules of detergent-solubilized two-color
SERCA. (D) Histogram of the fluorescence lifetime measurements obtained
from two-color RG-SERCA (red) or control GFP-SERCA (black). (E) Histo-
gramof FRETefficiency calculated from the lifetimemeasurements shown in
panel D. Gaussian fit revealed subpopulations consistent with four discrete
conformations of SERCA. (F) CY-SERCA also exhibited four discrete
FRET states. The reduced FRET of these states (compared to panel E) was
consistent with a shorter R0 for the Cer-YFP FRET pair. (G) RG-SERCA sin-
gle-molecule FRET time trajectory. (Horizontal lines indicate States I–IV
(orange through green) identified by Gaussian analysis, as in panel E). The
pump is observed to transiently sample the low FRET state (at arrow), before
returning to higher FRET conformations, suggesting that State I does not
represent denatured protein. (H) Analysis of dwell time for SERCA-sampling
States I–IV revealed a biphasic distribution of dwell times characterized by
fast (80 ms) and slow (690 ms) kinetics. To see this figure in color, go online.
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(PLB). The constructs also exhibited conformation-depen-
dent FRET. In particular, a construct with the fluorescent
proteins fused to the A- and N-domains showed decreased
FRET with thapsigargin (Tg) and increased FRET with
Ca. The data suggested that the donor-acceptor distance
decreased with the E2-to-E1 conformational change,
consistent with a closure of the SERCA cytoplasmic
headpiece (16).
Here we extend this work with an improved two-color
SERCA that benefits from a higher efficiency FRET pair
(RG-SERCA, Fig. 1 B). We also used a quantitative spectro-
scopic method that resolves SERCA structural heterogene-
ity. The goal of these experiments was to identify discrete
structural substates of SERCA and quantify the population
of those states in live cells. In particular, we measured
dynamic changes in the distribution of SERCA among
several discrete conformations in electrically paced adult
ventricular myocytes.MATERIALS AND METHODS
Molecular biology and cell culture
The engineering and functional characterization of two-color SERCA was
described in detail in Hou et al. (16). For some of these experiments we
used a rabbit SERCA2a construct (i.e., residue 509) described in Hou
et al., which is labeled with Cerulean on the N-terminus and an EYFP intra-
sequence tag inserted before residue 509 on the SERCA nucleotide-binding
domain. This Cer/YFP construct is referred to as ‘‘CY-SERCA’’ here. We
also used an analogous construct, ‘‘RG-SERCA’’, in which the N-terminus
was fused to TagRFP and EGFP was inserted as an intrasequence tag before
residue 509 in the N-domain. The Cer-YFP pair has a Fo¨rster distance (R0)
of 49.8 A˚ and the GFP-TagRFP pair has an R0 of 58.3 A˚ (26).
Expression of two-color SERCA in AAV-293 cells was performed as pre-
viously described in Hou et al. (16) and Kelly et al. (27). Briefly, cells were
transfected with plasmids encoding two-color SERCA using the MBS
mammalian transfection kit (Agilent Technologies, Stratagene, La Jolla,
CA). The transfected cells were trypsinized and replated onto poly-D-
lysine-coated glass-bottom dishes and allowed to attach for 2–4 h before
being used for measurements. Cotransfection of two-color SERCA with
nonfluorescent S16A-PLB or S16E-PLB was performed at a plasmid/molar
of 1:10.
For single-molecule experiments, the protein was solubilized in deter-
gent as follows: 0.1% dodecylphosphocholine (Sigma-Aldrich, St. Louis,
MO) in phosphate-buffered saline was gently layered over AAV-293 cells
expressing two-color SERCA, and incubated at room temperature for
45 min and sonicated for 2 min. The solution was withdrawn and centri-
fuged at 16,000 g for 10 min, and the supernatant was transferred to a cham-
bered coverglass (MatTek, Ashland, MA) for spectroscopy.
Adenoviral vectors of two-color SERCAwere prepared using the AdEasy
Adenoviral Vector System (Agilent Technologies, Santa Clara, CA). Adult
cardiac ventricular myocytes were enzymatically isolated from adult New
Zealand White rabbits (28). All protocols were approved by the Loyola
University Chicago Institutional Animal Care and Use Committee.
Myocytes were transferred to culture vessels and washed with fresh PC-1
medium (Lonza, Basel, Switzerland). Two-color SERCA adenoviruses
were added at a multiplicity of infection of 1000.
Cells were paced for 48 h in culture using a C-Pace EP pacer (IonOptix,
Milton, MA) set to 10 volts with a frequency of 0.1 Hz and 5-ms pulse dura-
tion. Typically, 50% of cells were rod-shaped after 48 h in culture, and 80%Biophysical Journal 105(8) 1812–1821
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cent cells was not increased by a multiplicity of infection of 10,000. During
spectroscopy experiments, electrical pacing of cardiac myocytes was per-
formed with a stimulator (Grass S44; Astro-Med, West Warwick, RI),
with 50-V stimulation, 5-ms duration, 0.25 Hz. The onset of contraction
after a stimulus was detected as a motion deflection of fluorescence inten-
sity. Data were integrated from multiple consecutive contraction/relaxation
cycles, with systole measurements taken from a 800-ms interval beginning
after the onset of contraction, and diastole measurements were taken from
an 800-ms interval beginning 100 ms after contraction was complete.TABLE 1 The FRET efficiency of discrete FRET substates and
corresponding fluorescent protein chromophore separation





CY-SERCA RG-SERCA CY-SERCA RG-SERCA
I 0.0045 0.004 0.0535 0.002 NDa 94.25 0.5
II 0.0655 0.004 0.1545 0.002 77.85 0.9 77.45 0.2
III 0.1205 0.002 0.2535 0.002 69.45 0.7 69.85 0.1
IV 0.2105 0.006 0.3495 0.003 62.15 0.4 64.75 0.2
Distances were calculated using R0 values of 49.8 A˚ for CY-SERCA and
58.3 A˚ for the RG-SERCA. Values are mean 5 SE.
aNot determined.Time-resolved fluorescence spectroscopy and
imaging
Time-correlated single-photon counting (TCSPC) and fluorescence imag-
ing were performed on an inverted confocal microscope (TCS-SP5; Leica
Microsystems, Buffalo Grove, IL) equipped with a 63 1.20 NA water
immersion objective (Leica Microsystems) and a pulsed Ti-Sapphire laser
(Coherent, Bloomfield, CT), with excitation at 840 nm. Emission was split
by a dichroic filter centered at 560 nm and passed through filters of 500–
550 nm (for EGFP fluorescence) and 607–683 nm (for TagRFP fluores-
cence). Avalanche photo diodes (SPCM-AQRH; PerkinElmer, Waltham,
MA) were used for detection of photons. The signals from the photo diodes
passed to a pulse inverter (APPI-D; Becker & Hickl, Berlin, Germany) and
20-dB attenuator and a TCSPC router (HRT-41; Becker & Hickl) for simul-
taneous data collection of both emission channels. The signal output and
the routing information from the router were transmitted to a TCSPC
card (SPC-830; Becker & Hickl) to record temporal information for each
detected photon. A synchronization reference signal for the TCSPC mea-
surements was obtained by directing a portion of the excitation laser onto
a photodiode (PHD-400-N; Becker & Hickl).
Temporal information was recorded as two different time tags for each
detected photon: t1, the microscopic arrival time relative to the previously
measured synchronization reference signal, and t2, indicating the macro-
scopic arrival time of the photon measured with respect to the start of the
experiment. Time tag t1 provides information about the nanosecond-scale
fluorescence lifetime and t2 measures the timecourse of the experiment
with millisecond time resolution. TCSPC data were analyzed with a
sliding-scale method (29) to obtain fluorescence lifetime (t) histograms
from recorded photon arrival times. Briefly, the train of photons detected
in the FRET donor channel was analyzed in overlapping blocks of 200
consecutive photons, with t determined for each block by maximum-likeli-
hood estimation (30,31). A histogram of the t1 arrival times of the photons
was used to calculate the likelihood function. The probability distribution
for this histogram was approximated by a single exponential decay of the
form et=t . Maximizing the logarithm of the likelihood function for the sin-










where ni indicates the number of photons in the ith bin of the histogram, and
N ¼Pini. The value u is the width of the time bins in the histogram and
t1¼ iuwith 0% ti% T. The root of this equation yields the maximum-like-
lihood estimate of the t-value of the fluorophore for the corresponding t2
time bracket. The analysis was automated with a custom MATLAB pro-
gram (The MathWorks, Natick, MA). The method was validated by deter-
mining the fluorescence lifetime of Rhodamine 6G in water at room
temperature.
FRET efficiency was calculated from measured t-values according to the
relationship E¼ (1 – (tDA/tD)), where tDAvalues are measurements of two-
color SERCA fluorescence lifetime and tD is the average t of the donor-
alone control. FRET efficiency histograms were fit to a sum of four
Gaussian peaks with the program ORIGIN (OriginLab, Northampton,Biophysical Journal 105(8) 1812–1821MA). All fit parameters (the center value, the width, and the area of each
Gaussian) were iteratively varied until convergence was obtained. Param-
eter mean values were obtained from five independent measurements. In
some experiments, background autofluorescence and other light contamina-
tion contributes to a long lifetime peak in the lifetime histogram. The life-
time of that species is too long to be from a fluorescent protein tag, so it is
disregarded in the FRET analysis.FRET histogram analysis
Histograms for systole and diastole from the same measurement were glob-
ally fit for increased accuracy of the fitted parameters. The center values of
the multiple peaks and their widths were shared among these histograms,
whereas the areas of the Gaussians were fit independently. Global fitting
was also employed in AAV-293 cell measurements by splitting a measure-
ment in time to generate multiple histograms.
Average distances between fluorescent protein fusion tags attached to the
N- and A-domains of SERCAwere calculated from the center values of sub-
populations of the FRET efficiency distributions, and are given in Table 1.
Distances are obtained from the relationship R ¼ R0(E1  1)1/6, where R0
is the Fo¨rster distance for the FRET pair, and E is the FRET substate peak
central value, assuming random relative orientation of the fluorophores
(k2 ¼ 2/3). Attachment of the N-terminal fluorescent protein by a flexible
linker makes it likely that the probe will sample a wide range of orientations
(32) during the dwell time of two-color SERCA in a particular substate. The
Fo¨rster distance (R0) is 58.3 A˚ for the GFP-TagRFP pair and 49.8 A˚ for the
Cer-YFP pair (26). The fluorescent protein FRET pairs for CY-SERCA and
RG-SERCA have different R0, tD, and emission spectra. The constructs also
have reciprocal donor/acceptor positions. Despite these differences, the dis-
tances calculated from FRET substates were very similar for CY-SERCA
and RG-SERCA (Table 1). The agreement of these values suggests that
the probe separation distance estimate was not dominated by k2 or beat-
to-beat changes in pH or autofluorescence.Single molecule time trajectory analysis
FRET efficiency trajectories calculated for each single molecule transit
were obtained for analysis of SERCA structural dynamics. FRETefficiency
values measured from overlapping blocks of 200 consecutive photons were
assigned to specific conformational States I–IV identified from previous
Gaussian fitting of FRET efficiency histograms (Table 1). The full width
at half-maximum of each Gaussian distribution was used as a threshold
for substate assignment. The duration of time spent in each FRET state
before transition to another FRET state was quantified, and a histogram
of observed dwell times was generated using a custom analysis routine in
MATLAB. The histogram of the dwell times was fit by a biexponential
function.
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FRET in detergent solubilized two-color SERCA
To survey resolvable conformations of SERCA in vitro, we
performed pulsed excitation, single-molecule fluorescence
spectroscopy with fluorescence lifetime distribution anal-
ysis (FLDA) (30,31) using RG-SERCA solubilized in
dodecylphosphocholine. Fig. 1 C shows the GFP donor fluo-
rescence emission of RG-SERCA, with bursts of photons
indicating the transit through the excitation volume of deter-
gent micelles containing individual two-color SERCA
molecules. Fluorescence excited-state lifetimes (t) were
quantified using a sliding-scale analysis method (29). A his-
togram of measured t-values revealed a large range of life-
times from 1.8 to 3.3 ns (Fig. 1 D, red bars). The average
lifetime was decreased compared to a non-FRET control
(donor only) GFP-SERCA (Fig. 1 D, black striped bars),
consistent with robust intramolecular FRET for RG-
SERCA. Moreover, in contrast to the donor-alone t-distri-
bution, the RG-SERCA histogram exhibited several distinct
maxima (Fig. 1 D, red bars). The resolved t-subpopulations
suggest at least four discrete FRET states as the proteins
diffuse through the excitation volume, consistent with at
least four discrete conformations of the pump.
Similar results were obtained for CY-SERCA (see Fig. S1
in the Supporting Material). FRET efficiency histograms for
RG-SERCA (Fig. 1 E) or CY-SERCA (Fig. 1 F) were calcu-
lated from measured t-values according to the relationship
E ¼ (1 – (tDA/tD)), where tDA values are measurements
of two-color SERCA fluorescence lifetime and tD is the
average t-value of the donor-alone control. The measured
donor lifetime for Cer-SERCA control was 2.6 ns (see
Fig. S1), slightly less than the published Cer t-value of
2.99 ns (33). Fusion of Cer to a target protein has been
shown to decrease t-value (33). We obtained a t-value of
2.86 ns for GFP (Fig. 1 D), which was similar to the pub-
lished value of 2.96 ns (34). We noted that the discrete
subpopulations of two-color SERCA were well resolved,
with distributions that were somewhat less wide than the
donor only control. One possible explanation for this is
that FRET increasingly depletes donors the longer they
dwell in the excited state, effectively eroding the right
side of the Gaussian and narrowing the width of the lifetime
distribution. A four-peak Gaussian fit resolved FRET sub-
populations with center values of 0.05, 0.16, 0.25, and
0.34 for RG-SERCA (Fig. 1 E), and 0.01, 0.07, 0.12,
and 0.21 for CY-SERCA (Fig. 1 F). A summary of average
peak positions is provided in Table 1. We denote these
discrete states as I (orange), II (blue), III (red), and IV
(green), respectively.
The increased FRET efficiency values observed for RG-
SERCA substates compared to CY-SERCA are consistent
with a longer Fo¨rster distance (R0) for the GFP-TagRFP
pair (58.3 A˚) versus the Cer-YFP pair (49.8 A˚) (26). The
apparent separation distances of the fluorescent proteinchromophores were calculated according to the Fo¨rster
relationship (see Supporting Results in the Supporting
Material). For CY-SERCA, probe separation distances for
States II, III, and IV were 78, 69, and 62 A˚, respectively.
The FRET efficiency for State I was too low to determine
a probe separation distance for this FRET pair. For
RG-SERCA, the separation distance for States I, II, III,
and IV were 94, 77, 70, and 65 A˚, respectively, in good
agreement with the measurements made with the Cer-YFP
pair (Table 1).SERCA conformational dynamics
Detergent-solubilized single molecules yielded time-trajec-
tories of up to 800 ms in duration. These showed apparent
stochastic transitions between high and low FRET confor-
mations (Fig. 1 G). For comparison, the FRET efficiency
of States I–IV identified from the distribution analysis,
which is shown in Fig. 1 E, are marked in Fig. 1 G as hor-
izontal lines. The pump was observed to transiently sample
the open conformation (State I) before returning to high
FRET states during the time trajectories (Fig. 1 G, arrow).
Such reversibility suggests that the low FRET state does
not arise from denatured or proteolyzed two-color SERCA.
Analysis of the kinetics of single-molecule structure transi-
tions revealed that SERCA samples States I–IV for variable
durations. A histogram of measured substate persistence
revealed a biphasic distribution of SERCA dwell times
(Fig. 1 H). An exponential fit of this distribution showed
the transitions fall into two distinct time regimes. The sig-
nificance of these two dynamics regimes is not clear. The
fast structure fluctuations (80 ms) may represent Brownian
dynamics of the N- and A-domains whereas the slower fluc-
tuations (690 ms) may correspond to catalytic transitions
between discrete enzymatic substates. Indeed, stochastic
thermal fluctuations may power the more deliberate struc-
ture transitions of catalysis. The overall rate of transitions
increased from 995 55 to 2005 61 transitions per minute
with the addition of 2 mM Ca.
In general, single-molecule FLDA experiments provided
good resolution of discrete FRET states and the transitions
between these states. Importantly, because of the small num-
ber of molecules sampled, we do not make conclusions
about the fractional abundance of particular states in such
experiments. The relative population of states was investi-
gated in detail in live cells in experiments described below.Two-color SERCA expressed in cardiac myocytes
To investigate the structural heterogeneity of SERCA in car-
diac muscle, we expressed two-color SERCA in cultured
enzymatically isolated rabbit myocytes. We observed a
range of expression levels in the population of infected cells.
Bright cells were used for confocal imaging of two-color
SERCA; for spectroscopy, very dim cells were selected toBiophysical Journal 105(8) 1812–1821
FIGURE 2 Two-color SERCA expressed in adult ventricular cardiac
myocytes. (A) Localization of RG-SERCA GFP fluorescence in adult ven-
tricular myocytes. (B) Localization of RG-SERCA TagRFP fluorescence.
(C) FRET distribution of two-color SERCA in electrically paced myocytes,
during the relaxation phase (diastole). (D) Systole (during the contraction
phase). (E) Diastole, plus isoproterenol. (F) Systole, plus isoproterenol.
(G) Summary of FRET subpopulations during diastole before (solid bars)
or after addition of isoproterenol (striped bars). (H) Systole, before (solid
bars) or after addition of isoproterenol (striped bars). (I) FRET distribution
after addition of Tg. (J) Summary of data in panel I. Panels C–F and I are
representative data obtained from individual cells; each histogram inte-
grates multiple consecutive contraction/relaxation cycles. Panels G, H,
and J are mean5 SE of all data. To see this figure in color, go online.
1816 Pallikkuth et al.reduce the concentration of exogenous protein to minimize
the number of fluorescently tagged proteins in the excitation
volume. This is a key condition to reduce ensemble aver-
aging and obtain optimal sampling of the distribution of
SERCA structural substates. Fig. 2, A and B, shows confocal
fluorescence images of RG-SERCA at 40 h postinfection.
Two-color SERCA fluorescence was distributed in striations
and longitudinal streaks, suggesting localization in the junc-
tional and transverse sarcoplasmic reticulum, respectively.
The localization of RG-SERCA and CY-SERCA (see Fig
S2, A and B) were similar to mCer-SERCA2a localization
in adult cardiac myocytes (35). Cardiac myocytes express-
ing a low concentration of RG-SERCA were selected for
FLDA. Ca release and contraction/relaxation were induced
by electrical pacing.
Because the t-value is independent of fluorescence inten-
sity, FLDA measurements were not subject to motion arti-
facts generated by myocyte contractions. Fig. 2, C and D,
shows examples of FRET efficiency histograms obtained
during diastole (relaxation) and systole (contraction),
respectively. The distributions were well described by a fit
to three Gaussian subpopulations, consistent with three
discrete FRET states, corresponding to at least three distinct
contemporaneous conformations of SERCA. The parame-
ters of the Gaussian fits were all freely variable, so it is note-
worthy that the center FRET efficiency values of the
subpopulations closely matched States I, II, and III previ-
ously identified in detergent-solubilized SERCA (as in
Fig. 1). Interestingly, the high FRET state (IV) observed
in single-molecule experiments (Fig. 1, E and F) was not
detected under these conditions; fitting to four Gaussian
populations returned zero amplitude for the fourth peak
(Fig. 2, C and D, green). The relative population of each
state was quantified from the area under the Gaussian for
each independent experiment. Combined data are summa-
rized in Fig. 2, G and H, as mean5 SE. Overall, the major-
ity of SERCA resided in low FRET states (I and II) during
diastole. With the increase in Ca during systole, the popula-
tion of high FRET State III increased from 12.3 to 34.7% of
total (Table 2). Gains in State III came at the expense of the
population of low FRET efficiency State I and to a lesser
extent, State II (Fig. 2, G and H, and Table 2).
An alternative analysis examined the time-dependent
changes in the populations of SERCA substates with
100-ms time resolution (see Fig. S3). The improved time
resolution came at the expense of state discrimination, but
despite rather noisy signals, we were able to observe a tran-
sient increase in the population of high FRET states after an
electrical stimulus (see Fig. S3 A, arrow), with a concomi-
tant decrease in the relative population of low FRET states
(see Fig. S3 B). After several hundred milliseconds, the
population relaxed again and remained in favor of predom-
inantly low FRET (~80% I and II) for the balance of dias-
tole. Overall, the data suggest that Ca binding to SERCA
stabilizes a compact, high FRET structure (III) (Fig. 2 D),Biophysical Journal 105(8) 1812–1821consistent with our previous observation that two-color
SERCA average FRET increased with Ca ((16) and S. J.
Gruber, R. L. Cornea, J. Li, K. C. Peterson, T. M. Schaaf,
TABLE 2 Changes in the relative population of discrete FRET
substates in cardiac myocytes, expressed as a percent of total
RG-SERCA FRET substate population (%), in cardiac myocytes
State
Control 100 mM Iso
10 mM TgDiastole Systole Diastole Systole
I 54.55 6.8 34.95 7.6 61.35 10.7 34.95 2.8a 55.55 3.0
II 33.25 5.3 30.45 4.5 29.25 8.4 24.95 2.0 44.55 3.0
III 12.35 3.1 34.75 5.0b 9.45 2.6 26.45 3.5b NDc
IV NDc NDc 0.15 0.1 13.85 2.8 b NDc
Values are mean 5 SE.
ap < 0.05 versus diastole.
bp < 0.01 versus diastole.
cNot determined.
SERCA Structural Substates Quantified by FRET 1817G. D. Gillispie, R. Dahl, K. M. Zsebo, S. L. Robia, and D. D.
Thomas, unpublished).
We also investigated the effect of adrenergic stimulation
on SERCA structural heterogeneity. The effect of b-agonist
(isoproterenol)was not apparent during diastole,with thema-
jority of SERCAassuming lowFRET conformations (States I
and II) (Fig. 2 E), similar to untreated myocytes (Fig. 2 C).
However, the effect of b-agonist was revealed during systole,
with a significant fraction of pumps switching to the latent
high FRET state (IV) (Fig. 2 F, Table 2, and see Fig. S2)
that was first observed in detergent-solubilized SERCA
(Fig. 1, E and F). The observed high FRET efficiency indi-
cates this unique structure is characterized by a very tightly
closed cytoplasmic headpiece. One possible interpretation
of this result is that the high FRET state results from unbind-
ing of PLB from SERCA (13,36). The alternative interpreta-
tion that we prefer is that PLB remains associated with
SERCA after phosphorylation, and together with elevated
Ca, stabilizes SERCA in a new conformation (37–40). These
two alternative mechanisms are directly tested below.
It is interesting that a relatively small fraction of the
SERCA population in cultured myocytes switch from the
prevailing low FRET states in diastole (Fig. 2, C and E) to
high FRET states in systole (Fig. 2, D and F). Indeed, under
physiological conditions the population of SERCA is not ex-
pected to synchronously transition between various substates
en masse. The density of SERCA in the SR is such that each
pump would only have to turn over once to completely
sequester available Ca (41). The results underscore the value
of lifetime distribution analysis for handling structural het-
erogeneity in the population of proteins. Conventional
FRET measurements report the average of all contempora-
neous conformations, blurring substates and reducing the
apparent magnitude of conformational changes.
Overall, experiments with electrically paced cardiac
myocytes suggest that low FRET states (I and II) correspond
to Ca-free (E2) conformations whereas high FRET states
(III and IV) correspond to Ca-bound conformations. Consis-
tent with this interpretation, Tg treatment abolished states
III and IV, leaving SERCA approximately evenly divided
between States I and II (Fig. 2, I and J). Tg inhibits SERCAactivity, and is commonly used to lock SERCA into a state
that is taken as a surrogate for E2 (21,42). Others have
demonstrated that SERCA cytoplasmic domains are still
dynamic after Tg binding (43); our data further suggest
that Tg-bound SERCA in the E2 enzymatic substate sam-
ples at least two discrete conformations.FRET in two-color SERCA transfected AAV-293
cells
To directly test whether State IV represents a PLB-free
SERCA structure or a unique phosphorylated PLB-SERCA
regulatory complex conformation, we quantified the distri-
bution of RG-SERCA conformations in AAV-293 cells,
which lack endogenous PLB. Confocal microscopy revealed
the expected colocalization of the fluorescence of the GFP
(Fig. 3 A, green) and TagRFP (Fig. 3 B, red) in internal
membrane structures, as was observed previously for CY-
SERCA (16), Cer-SERCA (35,44), and CFP SERCA
(27,38). The FRET efficiency histogram did not present
the high FRET state (IV), whether SERCA was expressed
alone (Table 3) or with nonphosphorylatable mutant
S16A-PLB (Fig. 3, C and D). Interestingly, coexpression
of PLB containing a mutation that mimics phosphorylation
by PKA (S16E-PLB) restored the population of State IV, but
only in cells that were treated with ionomycin to increase
cytosolic Ca (Fig. 3 F) (Table 3). It is not clear why the
fourth state, clearly resolved in detergent solution (Fig. 1,
E and F), is suppressed in heterologous cells (Fig. 3, C–E)
and cardiac myocytes (Fig. 2, C–E). It is also not known
why the combination of Ca and PLB phosphorylation
uncovers this latent conformation (Figs. 2 F and 3 F).
The data are not consistent with the model in which phos-
phorylation andCa relieve SERCA inhibition by dissociating
the PLB-SERCA regulatory complex (13,36), because State
IV is not observed in the absence of PLB (Table 3). Previ-
ously, we (Z. James, J.E. McCaffrey, ., D.D. Thomas.
Unpublished) (35,37–38,45) and others (40,46–48) have
provided evidence that relief of SERCA inhibition does not
require dissociation of PLB. We have proposed that PLB
phosphorylation alters the quaternary conformation of the
PLB-SERCA complex, without dissociation of the proteins.
State IV observed here may correspond to this disinhibited
conformation, a unique structure with a very tight headpiece
conformation (probe separation distance 62–65 A˚). Some
reports suggest that phosphorylated PLB provides SERCA
with an alternative kinetic pathway (47), enhancing its cata-
lytic efficiency (49–51). The high FRET State IV observed
here may represent an activated intermediate substate in
this putative alternative pathway.Magnitude of E2/E1 structure transition
It is noteworthy that there is a 30 A˚ difference in distance
between the most extreme open E2 (I) and closed E1 statesBiophysical Journal 105(8) 1812–1821
FIGURE 3 Expression of two-color SERCA in AAV-293 cells. (A)
Localization of RG-SERCAGFP fluorescence in AAV-293 cells. (B) Local-
ization of RG-SERCATagRFP fluorescence. (C) FRET distribution of two-
color SERCA and nonphosphorylatable PLB in intact cells. (D) As in panel
C, plus ionophore. (E) Two-color SERCA plus phosphomimetic PLB. (F)
As in panel E, plus ionophore. (G) Summary of FRET subpopulations
from intact cells expressing two-color SERCA and nonphosphorylatable
PLB (solid bars) or phosphomimetic PLB (striped bars). (H) Plus iono-
phore, with nonphosphorylatable PLB (solid bars) or phosphomimetic
PLB (striped bars). (I) FRET distribution after addition of Tg. (J) Summary
of I. Panels C–F and I are representative data obtained from individual cells.
Panels G, H, and J are mean5 SE of all data. To see this figure in color, go
online.
1818 Pallikkuth et al.(IV) (Table 1). This is a larger difference than would be pre-
dicted from x-ray crystal structures. Significant structures
(19) from recent x-ray crystallography studies show onBiophysical Journal 105(8) 1812–1821average a ~6 A˚ difference in the distance between the
FRET donor and acceptor fusion sites for E1 structures
versus E2 structures. A significant outlier is the first E1 crys-
tal structure 1SU4, characterized by a widely open head-
piece structure. It has been proposed that this was an
artifact arising from the absence of nucleotide in the crystal-
lization conditions (23,52). Although we did not directly
detect an open E1 structure, the presence of a very low
FRET E2 state with a 94 A˚ probe separation distance sug-
gests that the 1SU4 structure represents a real conformation
that is significantly populated in vivo (Table 2). We do not
think it likely that the low FRET state arises from partially
expressed proteins lacking the acceptor fluorophore,
because the pump was observed to reversibly sample this
state (Fig. 1 G). Moreover, State I was observed for both
RG-SERCA (Fig. 1 E) and CY-SERCA (Fig. 1 F), which
have a different order of translation of donor and acceptor
probes.Differential disorder of SERCA structures
In addition to revealing the intrinsic FRET efficiency of
discrete FRET states, Gaussian fitting also provided esti-
mates of the variability of FRET observed for each state.
These parameters are obtained from the peak center position
and peak width, respectively. In general, histograms
obtained from dilute single molecules in detergent solution
were better resolved than those obtained from a higher den-
sity of fluorescent molecules in cell membranes. This is
consistent with the expected ensemble averaging of multiple
molecules diffusing simultaneously through the excitation
volume in the cell. However, despite some loss of peak res-
olution in live cell experiments, we were still able to observe
an inverse relationship between Gaussian width and peak
center position (Fig. 4 A), irrespective of iso or Tg treatment.
The data show that as FRET increases, the variability of
FRET decreases. CY-SERCA showed the same trend, and
the peak widths were similar to those obtained for RG-
SERCA, although the reduced Cer-YFP R0 resulted in corre-
spondingly decreased FRET for each state (Fig. 4 B). That
the two constructs gave similar peak widths despite different
Fo¨rster distances supports the conclusion that the Gaussian
widths are set by SERCA structural disorder. Specifically,
the inverse relationship of peak width and peak center posi-
tion indicates that the domain separation distance becomes
increasingly well defined with closure of the cytoplasmic
headpiece.
Overall, the results suggest a high degree of cytoplasmic
domain structural disorder for open structures, and a
well-defined, rigid architecture for compact structures. It
is possible that high-FRET, tightly closed conformations
are stabilized by domain-domain contacts, whereas open
conformations are unconstrained and floppy. The func-
tional consequence of dynamic open architecture may be
enhanced mobility of the nucleotide binding domain during
TABLE 3 Changes in the relative population of discrete FRET substates in AAV-293 cells, expressed as percent of total
RG-SERCA FRET substate population (%), in AAV-293 cells
State
S16A-PLB S16E-PLB
10 mM Tg no PLBLow Ca High Ca Low Ca High Ca
I 47.25 4.8 46.85 3.7 41.55 4.4 33.65 2.3 62.05 7.2 12.85 3.7
II 34.15 5.4 35.65 5.5 38.35 4.9 30.65 5.3 38.05 7.2 58.25 12.5
III 18.65 4.1 17.65 2.5 20.25 3.6 29.45 5.0 NDa 28.25 12.0
IV NDa NDa NDa 6.35 1.5 NDa NDa
Values are mean 5 SE.
aNot determined.
SERCA Structural Substates Quantified by FRET 1819its Brownian search for ATP substrate. We have previously
proposed that Ca-free (E2) SERCA can assume an open
headpiece conformation (16). This hypothesis is compatible
with our data. Specifically, we observe several dynamic, low
FRET structures in low Ca (States I and II), and these struc-FIGURE 4 Comparison of FRET histogram Gaussian fit width versus
center position data obtained from cardiac myocytes. (A) States I–IV for
RG-SERCA showed that the population Gaussian width decreased with
increasing population Gaussian center value. This relationship was not
detectably altered by Tg (triangles) or iso (squares) compared to control
(circles). The data suggest that low FRET (open) conformations are more
dynamically disordered than high FRET (solid) structures. (B) Average
RG-SERCA peak parameters (black) compared with CY-SERCA (blue).
The shorter R0 of the Cer/YFP pair yielded decreased FRET (decreased cen-
ter values), but similar Gaussian widths for each state. Data are mean5 SE.
Proposed novel conformation of SERCA: (C) open E2 (Ca-free) SERCA,
characterized by a dynamically disordered cytoplasmic headpiece; and (D)
proposed closed E1 (Ca-bound) SERCA, with a rigidly ordered headpiece.
The conformation represents a uniqueE1 state that is stabilized by phosphor-
ylated phospholamban. To see this figure in color, go online.tures are stabilized by Tg. We did not resolve any new peaks
after Tg addition, consistent with the recent crystallographic
study showing that Tg stabilizes an existing E2 state without
distorting ATPase structure (53). During the preparation of
this manuscript, Akin et al. reported a crystal structure of
Ca-free SERCA bound to PLB, which showed an open cyto-
plasmic headpiece (54). We consider that structure to be
compatible with our present evidences for a dynamic open
E2. Conversely, the compact and ordered structure of State
IV (E1-SERCA bound to phosphorylated PLB) makes it an
interesting candidate for high-resolution structure studies.
Previously, cocrystallization studies have focused on
capturing the regulatory complex of PLB with E2-SERCA
(54–56).
Recently, several groups successfully obtained high-reso-
lution structures of sarcolipin bound to SERCA in an Mg-
bound E1 state (53,57). Sarcolipin is a peptide regulator
analogous to PLB, and has been shown to remain bound
to SERCA in the presence and absence of Ca (14,53,58).
We take this as consistent with our contention that regulato-
ry partners may interact with both E1 and E2-SERCA (45),
albeit with decreased affinity (35). We have speculated that
the PLB-E1-SERCA binding interface is distinct from the
canonical M2/M6/M9 binding groove on E2-SERCA (35).
This may be why PLB-SERCA cross-linking is reduced
(53) or abolished (13,14,54,58) by Ca while SERCA-PLB
FRET is preserved.CONCLUSIONS
We have determined that the new FRET construct RG-
SERCA was properly localized, functional, and responsive
to conformational changes. Reversible transitions among
four discrete conformations are consistent with fast
(80-ms) Brownian motions and slow (690-ms) catalytic
motions. These are large-amplitude transitions, producing
a ~30 A˚ change in FRET pair separation distance. Low
FRET states are consistent with open, dynamic structures,
and prevail in the low Ca conditions that favor the SERCA
E2 enzymatic substate. High Ca, which favors the SERCA
E1 substate, stabilizes high FRET states, with closed,
rigidly ordered cytoplasmic headpiece conformations.
The data are consistent with our previous conclusionBiophysical Journal 105(8) 1812–1821
1820 Pallikkuth et al.that the SERCA cytoplasmic headpiece closes with
Ca-binding (16).
Significantly, in all conditions we observed considerable
heterogeneity. In particular, although we predicted SERCA
inhibition would lock the pump into a single conformation
and simplify the FRET histogram to a single peak, multiple
discrete conformations were still present after addition of
Tg. The inhibitor eliminated two of the substates, but two
remain, and we observed reversible transitions of the in-
hibited pump between these discrete states. Such heteroge-
neity was not predicted by the many Tg-bound structures
available in the literature. Thus, apparently homogenous
subconformations of SERCA, such as obtained in x-ray
crystallography, may not represent the true dynamic struc-
ture of the ATPase. Instead, presumed enzymatic substates
may actually be an ensemble of degenerate conformations.
Consistent with our previous studies, phosphorylation of
phospholamban did not dissociate it from SERCA (38),
nor does Ca-binding to SERCA abolish the regulatory
complex (35). Instead, Ca-binding to SERCA and phospho-
lamban phosphorylation together induce the SERCA cyto-
plasmic headpiece to sample a unique high FRET
conformation. Taken together, the results predict several
novel states that are not represented in the available x-ray
crystal structures: an E2 state with a dynamically disordered
open cytoplasmic headpiece (Fig. 4C), and a tightly closed
E1-Ca-SERCA bound to phosphorylated PLB (Fig.4D).SUPPORTING MATERIAL
Supplemental Results, CY-SERCA FLDA, RG-SERCA FLDA, Histogram
Analysis, and four figures are available at http://www.biophysj.org/
biophysj/supplemental/S0006-3495(13)01017-5.
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